The NMDA receptor complex is altered in an animal model of human cerebral heterotopia

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 6, 2003, Pages 662-675

  Gardoni, Fabrizio ^a   Pagliardini, Silvia ^b   Setola, Veronica ^b   Bassanini, Stefania ^b   Cattabeni, Flaminio ^a   Battaglia, Giorgio ^b   Di Luca, Monica ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Cerebral dysgenesis; Epilepsy; Glutamate; Methylazoxymethanol (MAM); NMDA receptor complex; CaMKII

Indexed keywords

CELL PROTEIN; METHYLAZOXYMETHANOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MALFORMATION; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HETEROTOPIA; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; NERVE CELL; NEWBORN; NONHUMAN; POSTSYNAPTIC MEMBRANE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REDUCTION;

EID: 0038143615     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.6.662     Document Type: Article

References (44)

1. Galaburda AM, Sherman GF, Rosen GD, Aboitz F, Geschwind N. Developmental dyslexia: Four consecutive cases with cortical anomalies. Ann Neurol 1985;18:222-33
2. Kuzniecky R, Andermann F, Guerrini R. Congenital bilateral perisylvian syndrome: Study of 31 patients. The CBPS Multicenter Collaborative Study. Lancet 1993;341:608-12
3. Barkovich AJ, Guerrini R, Battaglia G, et al. Band heterotopia: Correlation of outcome with magnetic resonance imaging parameters. Ann Neurol 1994;36:609-17
4. Hardiman O, Burke T, Phillips J, et al. Microdysgenesis in resected temporal neocortex: Incidence and clinical significance in focal epilepsy. Neurology 1988;38:1041-47
5. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995;54:137-53
6. Battaglia G, Granata T, Farina L, D'Incerti L, Franceschetti S, Avanzini G. Periventricular nodular heterotopia: Epileptogenic findings. Epilepsia 1997;38:1173-82
7. Jones MZ, Gardner E. Pathogenesis of methylazoxymethanol-induced lesions in the post-natal mouse cerebellum. J Neuropathol Exp Neurol 1976;35:413-44
8. Cattabeni F, Di Luca M. Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev 1997;77:199-215
9. Sancini G, Franceschetti S, Battaglia G, et al. Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: An intracellular study of identified pyramidal neurons. Neurosci Lett 1998;246:181-85
10. Colacitti C, Sancini G, Franceschetti S, et al. Altered connections between neocortical and heterotopic areas in methylazoxymethanol-treated rat. Epilepsy Res 1998;32:49-62
11. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994;17:31-108
12. During MJ, Symes CW, Lawlor PA, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000;287:1453-60
13. Kennedy MB. Signal-processing machines at the postsynaptic density. Science 2000;290:750-54
14. Strack S, McNeill RB, Colbran RJ. Mechanism and regulation of calcium/calmodulin-dependent protein kinase II targeting to the NR2B subunit of the N-methyl-D-aspartate receptor. J Biol Chem 2000;275:23798-806
15. Gardoni F, Schrama LH, Kamal A, Gispen WH, Cattabeni F, Di Luca M. Hippocampal synaptic plasticity involves competition between αCaMKII and PSD-95 for binding to the NR2A subunit of the NMDA receptor. J Neurosci 2001;21:1501-9
16. Kornau HC, Schenker LT, Kennedy MB, Seeburg PH. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 1995;269:1737-40
17. Colacitti C, Sancini G, De Biasi S, et al. Prenatal Methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses. J Neuropathol Exp Neurol 1999;58:92-106
18. Gardoni F, Schrama LH, van Dalen JJW, Gispen WH, Cattabeni F, Di Luca M. αCaMKII binding to the C-terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation. Febs Lett 1999;456:394-99
19. Gardoni F, Caputi A, Cimino M, Pastorino L, Cattabeni F, Di Luca M. Calcium/calmodulin-dependent protein kinase II is associated with NR2A/B subunits of NMDA receptor in postsynaptic densities. J Neurochem 1998;71:1733-41
20. Kim E, Cho KO, Rothschild A, Sheng M. Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins. Neuron 1996;17:103-13
21. Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 1999;284:1845-48
22. Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N- methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A 1999;96:435-40
23. Baraban SC, Schwartzkroin PA. Electrophysiology of CA1 pyramidal neurons in an animal model of neuronal migration disorders: Prenatal methylazoxymethanol treatment. Epilepsy Res 1995;22:145-56
24. Baraban SC, Schwartzkroin PA. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy Res 1996;23:189-94
25. Germano IM, Zhang YF, Sperber EF, Moshe SL. Neuronal migration disorders increase susceptibility to hyperthermia-induced seizures in developing rats. Epilepsia 1996;37:902-10
26. Germano IM, Sperber EF. Increased seizure susceptibility in adult rats with neuronal migration disorders. Brain Res. 1997;777:219-22
27. Chevassus-au-Louis N, Ben-Ari Y, Vergnes M. Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol. Brain Res 1998;812:252-55
28. Baraban SC, Wenzel HJ, Hochman DW, Schwartzkroin PA. Characterization of heterotopic cell clusters in the hippocampus of rats exposed to methylazoxymethanol in utero. Epilepsy Res 2000;39:87-102
29. Castro PA, Cooper EC, Lowenstein DH, Baraban SC. Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy. J Neurosci 2001;21:6626-34
30. Chevassus-au-Louis N, Baraban SC, Gaiarsa JL, Ben-Ari Y. Cortical malformations and epilepsy: New insights from animal models. Epilepsia 1999;40:811-21
31. Bronstein J, Farber D, Wasterlain C. Decreased calmodulin kinase activity after status epilepticus. Neurochem Res 1988;13:83-86
32. Bronstein JM, Micevych P, Popper P, Huez G, Farber DB, Wasterlain CG. Long-lasting decreases of type II calmodulin kinase expression in kindled rat brains. Brain Res 1992;584:257-60
33. 2+/calmodulin-dependent kinase II activity in the rat. Neuroscience 2000;95:735-43
34. 2+/calmodulin-dependent kinase II α-subunit mutation. Proc Natl Acad Sci U S A 1995;92:6852-55
35. 2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneus recurrent seizures. Brain Res 1999;851:54-65
36. Churn SB, Sombati S, Jakoi ER, Sievert L, DeLorenzo RJ. Inibition of Calcium/calmodulin kinase II alpha subunit expression results in epileptiform activity in cultured hippocampal neurons. Proc Natl Acad Sci U S A 2000;97:5604-9
37. Calcagnotto ME, Paredes MF, Baraban SC. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J Neurosci 2002;22:7596-7605
38. Battaglia G, Pagliardini S, Ferrario A, et al. αCaMKII and NMDA receptor subunit expression in epileptogenic cortex from human periventricular nodular heterotopia. Epilepsia (Suppl. 5) 2002;43:209-16
39. Rafiki A, Chevassus-au-Louis N, Ben-Ari Y, Khrestchatisky M, Represa A. Glutamate receptors in dysplasic cortex: An in situ hybridization and immunohistochemistry study in rats with prenatal treatment with Methylazoxymethanol. Brain Res. 1998;782:142-52
40. Ying Z, Babb TL, Comair YG, Bingamam W, Bushey M, Touhalsky K. Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropatol Exp Neurol 1998:47-62
41. Najm IM, Ying Z, Babb T, et al. Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 2000;41:971-76
42. Grosshans DR, Clayton DA, Coultrap SJ, Browning MD. LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nat Neurosci 2002;5:27-33
43. Dunah AW, Wang Y, Yasuda RP, et al. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 2000;57:342-52
44. Hannan AJ, Servotte S, Katsnelson A, et al. Characterization of nodular heterotopia in children. Brain 1999;122:219-38